Toll-like receptors (PP-001)

Autor: D. J. Weisdorf, C. Svanborg, Q. Wang, P. Ekpo, D. Kim, M. Park, X. Liang, H. J. Kwak, D. Spencer, N. Srisamut, P. Datta, L. Bulat-Kardum, H. D. Ochs, F. E. Sepulveda, L. Song, A. Kariyone, M. Ogasawara, J. Jang, A. Junpee, K. Agematsu, D. R. Stach-Machado, H. Kariya, Daniela Verthelyi, K. Itoh, K. Yamazaki, W. Cheng, K. Miyake, S. Rezania, Q. Zhang, H. O. Bianchi, Y. Takeda, S. M. Kim, C. M. Blum, S. Ohta, J. C. Lee, F. Liu, M. E. Abdalsalam, Y. Sher, J. Cho, N. Nilsen, S. Das, J. Munz, K. A. Fitzgerald, Y. Jung, S. Hellmig, J. Inoue, W. W. Agace, C. Knetter, S. Sasawatari, F. Willems, T. Tomita, S. Akira, C. A. Palha De Sousa, C. L. Zawislak, D. Cole, P. Thuss-Patience, H. Jarmer, T. Espevik, F. Shokri, Ihsan Gursel, H. Yang, J. Seo, C. Gfell, D. H. Kim, J. N. Smith, X. Shen, F. Skjeldal, O. Bakke, E. P. Sgroe, A. Lennon-Dumenil, T. Hayashi, S. Rasmussen, S. Hong, I. Chung, J. Conlon, L. Cabanie, S. Gretschel, Y. Zhang, Y. Sakurai, S. Amigorena, M. Hattori, A. Ta, J. Zhang, H. An, R. A. Kurt, M. A. Zacks, M. Shirakawa, J. S. Rush, N. Parvizzadeh, M. Chen, J. Y. Kang, S. Kim, M. L. Salem, C. Yang, S. Maschalidi, O. Kumpf, X. Cao, J. S. Miller, O. Naga, D. Kanistanon, J. Lee, B. R. Blazar, Y. Liu, V. Flamand, D. Wakita, L. Grajkowska, Özlem Aslan, T. Seya, R. Lindblom, P. Abrahão, C. Ghirelli, N. M. Rachmawati, H. Oshiumi, L. Lu, U. Rungpanich, K. Inaba, E. Moseman, T. Nishimura, F. Piehl, B. Manoury, B. Nøhr Nielsen, T. Sasazuki, C. Lin, J. A. Hamerman, R. Colisson, T. Nakahama, T. Funasaka, W. Bae, A. Hasebe, K. McMichael, B. C. Cole, Y. Suda, G. A. Obando-Pereda, E. K. Ryu, R. F. Ashman, A. G. D. Bean, A. Wang, B. Bohle, F. Golsaz Shirazi, K. Chakraborty, K. Tosh, T. Olsson, V. Bachanova, P. Lenert, C. J. Kirschning, N. Toyama-Sorimachi, M. Kimoto, S. Paessler, D. Yoo, S. J. Oh, C. Kitzmüller, M. Schmitz, D. Baltzis, K. Ono, A. J. Karpala, L. Hamann, M. Matsumoto, J. Lou, Z. Kato, J. Tak, N. Amirmozzafari, A. T. Egunsola, L. HjerrildZeuthen, Y. Tsai, B. Löbel, D. Wang, M. V. Zeid-Kilani, E. Lien, H. E. Park, H. Liu, A. Kimura, L. Chang, N. Rashidi, N. Kondo, C. Ouyang, J. Wang, H. Fischer, E. K. Persson, M. Yadav, P. Tanthuvanit, J. K. Smith, S. Taki, N. J. Nilsen, V. Younesi, R. Mitamura, H. Jähnisch, I. Chinen, J. Chen, T. Kimura, E. Quivy, M. A. Farrar, N. Abdelmagid, P. Wongprompitak, H. Y. Kim, A H Zarnani, B. Uleng, O. Leo, R. W. Wong, H. Rabbani, Gizem Tincer, S. Bolliger, W. Huang, T. Miethke, D. Rodionov, L. Heslop, N. Makiuchi, O. Moussa, Y. Lee, S. Tanaka, M. S. Lee, M. Hashimoto, K. Takatsu, L. Tussey, H. Kitamura, M. Diez, C. Wang, J. Lum, J. Dutz, M. Puig, G. Robert, Y. Nagai, K. Masuko, S. Liu, W. Chen, M. Arjmand, Z. Dembic, C. Scheibenbogen, H. Weng, T. Matsunaga, Y. Maru, S. Daum, M. Ikutani, Y. Tang, M. Mosallaei, S. Ye, H. Husebye, H. Nikzamir, S. Bauer, E. Yang, Ismail Simsek, Y. Deng, H. Frøkiær, H. Kao, G. Weiss, A. L. Poussard, G. E. Etokebe, R. R. Schumann, H. H. Mu, I. Choi, S. Deifl, K. Masuda, M. Montero-Diaz, T. Kishimoto, M. Yao, U. Kavita, E. Latz, N. E. Yun, H. Ohnishi, C. Leng, J. Knezevic, Q. Yuan, L. Katoozian, S. Koizumi, Y. Aoyagi, A. M. Crespo, S. Takao, A. P. Makrigiannis, R. Wehner, D. Bitchev, P. Chong, S. Nuchprayoon, H. S. Koh, J. W. Lowenthal, S. Chiou, S. Watanabe, R. Zhong, M. Yoshizaki, G. P. Garlet, H. Poo, H. Geng, T. Böldicke, D. Torres, J. Khoshnoodi, H. Chen, U. McKeever, S. Miranda-Hernandez, S. Mutschlechner, J. Goeken, S. Umlauf, H. Tochio, B. Weaver, S. Delbauve, M. Yousefi, J. R. Ribeiro dos Reis, K. Fukudome, K. Harnesk, N. K. Yee, G. Rivell, Seda Yerlikaya, E. Lüdeking, J. Y. Kim, N. Tsuneyoshi, A. Chou, H. Li, G. Liu, H. Tsukamoto, X. Liu, A. Hise, N. Li, P. Cohen, Fuat Cem Yagci, E. Jaensson

Publikováno v: International Immunology. 22:i10-i22

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::43f89ec8f0ca2428c506fdcbc718c62a
https://doi.org/10.1093/intimm/dxq076

Blockade of CD40 ligand-CD40 interaction impairs CD4+ T cell-mediated alloreactivity by inhibiting mature donor T cell expansion and function after bone marrow transplantation

Autor: B R Blazar, P A Taylor, A Panoskaltsis-Mortari, J Buhlman, J Xu, R A Flavell, R Korngold, R Noelle, D A Vallera

Publikováno v: The Journal of Immunology. 158:29-39

Alloreactive T cells require costimulatory signals via CD40 ligand (CD40L). The tissue-destructive properties of allogeneic CD4+ but not CD8+ T cells were inhibited by anti-CD40L mAb. Fewer CD4+ thoracic duct lymphocytes (TDL) were obtained in mAb-tr

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::bf975aeee70748f9371361b41bb4fe28
https://doi.org/10.4049/jimmunol.158.1.29

FK506 inhibits graft-versus-host disease and bone marrow graft rejection in murine recipients of MHC disparate donor grafts by interfering with mature peripheral T cell expansion post-transplantation

Autor: B R Blazar, P A Taylor, W E Fitzsimmons, D A Vallera

Publikováno v: The Journal of Immunology. 153:1836-1846

FK506 was evaluated as the sole graft-vs-host disease (GVHD) preventive agent in murine recipients of fully allogeneic donor grafts. FK506 (36 mg/kg given as a suspension on days 0 through 13, then three times per wk through day 29 post-bone marrow t

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::221cfb79e3300b6c6c017f38d5e84ba2
https://doi.org/10.4049/jimmunol.153.4.1836

In vivo or in vitro anti-CD3 epsilon chain monoclonal antibody therapy for the prevention of lethal murine graft-versus-host disease across the major histocompatibility barrier in mice

Autor: B R Blazar, P A Taylor, D A Vallera

Publikováno v: The Journal of Immunology. 152:3665-3674

We explored the use of a single in vivo dose of an anti-CD3 epsilon mAb for graft-vs-host disease (GVHD) prevention in mice. Anti-CD3 epsilon (145-2C11) given on the day of bone marrow (BM) transplant was highly effective in preventing GVHD in a dose

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::658d1ac24ac6def9944d6c42ae9fa228
https://doi.org/10.4049/jimmunol.152.7.3665

Nonmitogenic anti-CD3F(ab')2 fragments inhibit lethal murine graft-versus-host disease induced across the major histocompatibility barrier

Autor: B R Blazar, P A Taylor, D C Snover, J A Bluestone, D A Vallera

Publikováno v: The Journal of Immunology. 150:265-277

We have investigated the in vivo administration of nonmitogenic anti-CD3F(ab')2 fragments for the prevention of lethal graft-vs-host disease (GVHD) in irradiated recipients of fully allogeneic bone marrow cells plus splenocyte (BMS) inocula. Recipien

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::f736c5df13db2537965f9869451cd4cf
https://doi.org/10.4049/jimmunol.150.1.265